Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2023-07-17 Governance Information
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
投资者关系管理制度（2023年第一次修订）
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度（2023 年第一次修订）' which translates to 'Investor Relations Management System (2023 First Revision)'. It details the company's policies and procedures for managing investor relations, including communication principles, responsibilities, and operational guidelines. It is a governance-related document focusing on internal rules and management of investor relations rather than financial results, audit, or regulatory filings. It is not a report of financial performance, nor an announcement of voting results or capital changes. The content aligns with governance practices and internal management policies. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5770 characters) and detailed content support this classification with high confidence.
2023-07-17 Chinese
股东大会议事规则（2023年第一次修订）
Governance Information Classification · 100% confidence The document is titled "股东大会议事规则" which translates to "Shareholders' Meeting Rules" and details the rules and procedures for convening and conducting shareholders' meetings, including voting rights, meeting notices, proposal submissions, and board authorizations. It is a comprehensive governance document outlining internal rules for shareholder meetings rather than a report of financial results or an announcement of a meeting or voting results. There is no indication that this is a report of an AGM or a proxy statement, nor is it a financial report or an announcement of voting results. The content fits the description of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2023-07-17 Chinese
关于调整董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Beijing Kangle Weishi Biotechnology Co., Ltd. regarding adjustments to the members of the company's board committees. It details changes in the composition of the audit committee, strategy committee, nomination committee, and remuneration and assessment committee. The document is short (660 characters) and focuses solely on board committee membership changes without any financial data or report content. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-07-17 Chinese
关于调整公司内部管理机构的公告
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the adjustment of internal management structure. It mentions the board meeting and decisions about internal management institutions, focusing on governance and organizational changes. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, and no report publication. The content fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management or internal management structure.
2023-07-17 Chinese
防范控股股东、实际控制人及其他关联方资金占用制度（2023年第一次修订）
Governance Information Classification · 95% confidence The document is a detailed announcement of a corporate governance policy titled 'Prevention of Fund Occupation by Controlling Shareholders, Actual Controllers and Other Related Parties' by Beijing Kangle Weishi Biotechnology Co., Ltd. It includes the company's internal rules, responsibilities of directors and management, and procedures to prevent misuse of company funds by controlling shareholders and related parties. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a governance-related document outlining internal control policies and procedures. Therefore, it fits best under Governance Information (CGR). The document length is 3092 characters, which is sufficient for a substantive policy document rather than a brief announcement or certification.
2023-07-17 Chinese
总经理辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's general manager and the appointment of a new CEO. It details the resignation date, shareholding of the resigning executive, and the impact of the resignation on the company's board and operations. There are no financial statements, earnings data, or detailed financial analysis present. The document focuses on management changes, specifically the resignation and appointment of senior management personnel. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2023-07-17 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.